Have European Investors Missed the Exosome ‘Gold Rush’?
When Oxford-based Evox Therapeutics announced its €81.1M (£69.2M) Series C round in February, it signaled…
01/04/2021 - 5 minutes
Evox Therapeutics
Exosome Therapy: Borrowing from Nature’s Toolbox
In just a few years, exosomes have started gaining recognition as a solution to deliver…
24/02/2021 - 11 minutes
Evox and Lilly Partner to Develop Neuro RNA Drugs in Deal Worth €1.1B
British biotech Evox Therapeutics has signed a collaboration deal worth up to €1.1B with US…
11/06/2020 - 3 minutes
Evox Therapeutics Receives up to €800M from Takeda To Tackle Rare Diseases
The Japanese pharmaceutical company Takeda has struck a deal worth up to €803M with UK…
27/03/2020 - 3 minutes
